Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• BTIG Biotechnology Conference 2019 in New York, NY; USA

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences in August.

Click here to see the full Press Release